For refugee patients from Africa, which two intestinal parasites should be screened?

Screening refugee patients from Africa for Strongyloides and schistosomiasis is crucial due to the high prevalence of these parasites in many African regions. Strongyloides stercoralis can cause significant health issues, including chronic infections that may lead to severe complications, especially in immunocompromised individuals. Schistosomiasis, particularly from species such as Schistosoma mansoni and Schistosoma haematobium, is also commonly found in Africa and can result in long-term disease affecting various organ systems, including the urinary and gastrointestinal tracts.

These two parasites are often overlooked in routine screening but can lead to serious health implications if not diagnosed and treated. Given their prevalence and the potential for severe health outcomes, targeted screening for these parasites is an essential part of managing the health of refugee populations from areas where these infections are endemic.

In contrast, while other listed parasites may also have health implications, Strongyloides and schistosomiasis are of particular concern in the context of refugees from Africa, as they present more significant public health challenges and can lead to complications if not addressed appropriately.